Heidelberg Pharma AG
Heidelberg Pharma AG: Preliminary announcement of the publication of financial reports according to Articles 114, 115, 117 of the WpHG [the German Securities Act]
Heidelberg Pharma AG
/ Preliminary announcement on the disclosure of financial statements
Heidelberg Pharma AG hereby announces that the following financial reports shall be disclosed:
Report Type: Annual financial report Language: German Date of disclosure: March 25, 2024 Address: https://heidelberg-pharma.com/de/presse-investoren/mitteilungen-und-berichte/finanzberichte Language: English Date of disclosure: March 25, 2024 Address: https://heidelberg-pharma.com/en/press-investors/announcements/financial-reports Report Type: Annual financial report of the group Language: German Date of disclosure: March 25, 2024 Address: https://heidelberg-pharma.com/de/presse-investoren/mitteilungen-und-berichte/finanzberichte Language: English Date of disclosure: March 25, 2024 Address: https://heidelberg-pharma.com/en/press-investors/announcements/financial-reports Report Type: Financial report of the group (half-year/Q2) Language: German Date of disclosure: July 11, 2024 Address: https://heidelberg-pharma.com/de/presse-investoren/mitteilungen-und-berichte/finanzberichte Language: English Date of disclosure: July 11, 2024 Address: https://heidelberg-pharma.com/en/press-investors/announcements/financial-reports
22.01.2024 CET/CEST The EQS Distribution Services include Regulatory Announcements, Financial/Corporate News and Press Releases. |
Language: | English |
Company: | Heidelberg Pharma AG |
Gregor-Mendel-Str. 22 | |
68526 Ladenburg | |
Germany | |
Internet: | www.heidelberg-pharma.com |
End of News | EQS News Service |